OMERS ADMINISTRATION Corp Has $7.10 Million Holdings in HCA Healthcare, Inc. $HCA

OMERS ADMINISTRATION Corp raised its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 17.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,997 shares of the company’s stock after purchasing an additional 2,263 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in HCA Healthcare were worth $7,097,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in HCA. Palisade Asset Management LLC bought a new stake in HCA Healthcare during the 3rd quarter worth about $26,000. Ares Financial Consulting LLC bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $31,000. Cedar Mountain Advisors LLC bought a new position in HCA Healthcare in the 1st quarter worth approximately $33,000. MCF Advisors LLC increased its stake in shares of HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after buying an additional 49 shares during the period. Finally, Basepoint Wealth LLC acquired a new position in shares of HCA Healthcare during the fourth quarter valued at $35,000. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

HCA has been the topic of a number of research reports. Robert W. Baird cut their target price on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a report on Tuesday, July 7th. Wall Street Zen cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Oppenheimer reduced their price target on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Finally, Wells Fargo & Company set a $369.00 target price on HCA Healthcare in a research note on Monday, July 20th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $483.45.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA beat Q2 earnings estimates, reporting $7.59 per share versus expectations around $7.56-$7.57, while revenue rose 8.7% year over year to $20.23 billion and also topped estimates. HCA Healthcare earnings report
• Positive Sentiment: Management cited strong admissions and higher revenue per admission as key drivers of the quarter, suggesting healthy demand trends across its hospital network. Zacks article on HCA Q2 results
• Neutral Sentiment: HCA said its updated guidance is consistent with its earlier preview, so the quarter appears to confirm previously signaled results rather than deliver a major surprise. BusinessWire Q2 results
• Negative Sentiment: The company trimmed parts of its 2026 outlook, pointing to higher expenses and weaker surgical volumes as headwinds that could limit margin expansion. Zacks guidance revision article
• Negative Sentiment: Separate investor-law-firm investigations into HCA may add some legal overhang, though these notices are not operational results. Pomerantz investor alert

HCA Healthcare Trading Up 0.0%

HCA opened at $382.28 on Monday. The firm’s fifty day simple moving average is $386.95 and its 200 day simple moving average is $453.56. The stock has a market capitalization of $84.80 billion, a P/E ratio of 12.80, a P/E/G ratio of 1.29 and a beta of 1.12. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same period in the prior year, the firm earned $6.84 earnings per share. HCA Healthcare’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, equities research analysts predict that HCA Healthcare, Inc. will post 29.19 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s payout ratio is currently 10.45%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.